您的位置: 首页 > 农业专利 > 详情页

Compounds with activity and Muscarinic receptor antagonist activity of B2 adrenergic receptor agonist
专利权人:
CHIESI FARMACEUTICI S.P.A.
发明人:
RANCATI FABIO,RIZZI ANDREA,LINNEY IAN,KNIGHT CHRIS,BLACKABY WESLEY
申请号:
ARP120102063
公开号:
AR086896A1
申请日:
2012.06.08
申请国别(地区):
AR
年份:
2014
代理人:
摘要:
Processes for their preparation, compositions containing Same, Therapeutic uses and combinations with other pharmaceutically Active Ingredients.Claim 1: wherein is a compound of General formula (1), where q is a group of formula (Q1) (Q6); Z is H or Oh; and is - (CH2) n where n is an integer between 1 and 12 or a divalent Group of formula (2) A1 and A2 independently or are absent. Ccionan among the group consisting alquileno C1 - 6Cicloalquileno heterocicloalquileno C3 and C3 - 8 - 8; b is absent or is selected from the group consisting cicloalquileno heterocicloalquileno C3 C3 - 8, - 8, and heteroarileno arylene or is a group of formula (3); c is absent or is selected from the group consisting of - or - - or CO -, - C (o) o -, - S, - S (o) -,- S - and (OR) 2 - or - N (R4) is one of the remnants of the group of formulas (4) where it is R4 H or is selected from the group consisting of 8 C1 - C3 alkyl, cycloalkyl - 8 - 8 heterocicloalquilo C3, aryl and heteroaryl; d was selected from the group consisting alquileno C1 - C2 - alquenileno 12, 12 and alquini Leno C2 - 6Optionally substituted with one or more alkyl C1 - 6; R is H or alkyl - C1 - 4; X is - or or - S - H OR; r1 is selected from the group consisting of C3 - 8 cycloalkyl, aryl, heteroaryl, arylalkyl C1 - 6 - 6, heteroarilalquilo C1 and C3 cicloalquil - 8alquilo C1 - 6, optionally substituted with one or more More c1-4 alkoxy; R2 is selected from the group consisting of C3 - 8 cycloalkyl, aryl, heteroaryl,Arylalkyl C1 - 6 - 6, heteroarilalquilo C1 and C1 - C3 - cicloalquil 8alquilo 6, optionally substituted with one or more Atoms of halogen or c1-4 alkoxy; R3 is H or is selected from the group consisting hidroxialquilo C1 - Oh, - 6, - N and - N (r5r6) (R5) Co (r6); R5 and R6 are independently H or alqui The C1 - 6; and pharmaceutically acceptable salts or solvates thereof.Procesos para su preparación, composiciones que los comprenden, usos terapéuticos y combinaciones con otros ingredientes farmacéuticamente ac
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充